LEXINGTON, Mass.--(BUSINESS WIRE)--KSQ Therapeutics, Inc. ("KSQ"), a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics ® discovery platform, and CTMC, ...

CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases ...

Lymphocyte growth rate after CAR-T therapy predicts survival and toxicity in lymphoma. Discover how this biomarker could ...

Cancer immunotherapy has revolutionized treatment for many patients, but significant challenges remain in predicting who will respond to these life-saving treatments. A new comprehensive review ...

Neuroimmunology has demonstrated that T cells residing in the human brain constitute a distinct, tissue-adapted lymphocyte population. Unlike their ...

Lymphocyte-depleted Hodgkin’s lymphoma (LDHL) is a rare subtype of Hodgkin’s lymphoma, a cancer that develops in the lymphatic system. Hodgkin’s lymphoma (HL) is an uncommon cancer of the lymphatic ...

Nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL) is a cancer of the white blood cells. It differs from classic Hodgkin’s lymphoma. Nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL) ...

High neutrophils and low lymphocytes can mean your body is under severe stress or fighting an infection. The neutrophil-to-lymphocyte ratio (NLR) helps doctors understand how sick you are and what ...

The promise of tumor-infiltrating lymphocytes (TIL) therapy is expanding beyond melanoma to a wide range of solid tumors, but the path to clinical success remains complex. Variability in tumor tissue ...

Doctors monitor lymphocyte and other blood cell levels to predict how your lymphoma will progress. Low lymphocyte counts may suggest that cancer has spread to your bone marrow, or it can be a side ...